Valencia Vice President, Health Economics & Market Access (HEMA), Neuromodulation CA 91355

Job description

Additional Location(s): US-MA-Marlborough; US-MN-Maple Grove Diversity - Innovation - Caring - Global Collaboration - Winning Spirit - High Performance At Boston Scientific, we’ll give you the opportunity to harness all that’s within you by working in teams of diverse and high-performing employees, tackling some of the most important health industry challenges. With access to the latest tools, information and training, we’ll help you in advancing your skills and career. Here, you’ll be supported in progressing – whatever your ambitions. About the Role Boston Scientific is seeking a strategic leader to serve as Vice President, Health Economics & Market Access (HEMA) for Neuromodulation . As a member of the Neuromodulation Leadership Team, this senior leader will define and lead the global HEMA strategy, ensuring market access, reimbursement, health economics, evidence generation, and value communication are integrated across portfolio strategy, product development, commercialization, and lifecycle management. The Vice President will partner across global, regional, and functional teams to expand patient access, support adoption of innovative therapies, demonstrate clinical and economic value, and drive sustainable business growth. This leader will also build and develop a high-performing global HEMA organization while shaping future market access capabilities across the Neuromodulation franchise. Your Responsibilities Will Include: Global HEMA Strategy and Business Leadership • Define and lead the global HEMA vision and strategy for the Neuromodulation portfolio, aligned with business objectives and growth priorities. • Serve as a strategic member of the Neuromodulation Leadership Team, advising on market access, reimbursement, health policy, healthcare economics, and evolving payer and provider dynamics. • Establish HEMA priorities, investments, and measures of success to support patient access, therapy adoption, and commercial performance. • Drive alignment and execution of HEMA strategies across Neuromodulation and the broader enterprise. Portfolio and Product Strategy • Integrate market access, reimbursement, health economics, and evidence strategies into portfolio planning, product development, commercialization, and lifecycle management. • Lead global HEMA strategies for new and existing Neuromodulation therapies, including coverage, coding, payment, evidence generation, and value communication. • Partner cross-functionally to identify opportunities, mitigate access risks, and support product launches, therapy expansion, new indications, and business development activities. • Ensure payer, provider, and healthcare system perspectives inform portfolio prioritization and investment decisions. Reimbursement and Market Access • Lead global market access strategies that support coverage, coding, payment, and adoption of Neuromodulation therapies. • Provide expertise in global reimbursement environments, payer expectations, health technology assessment, healthcare policy, and U.S. coverage, coding, and payment pathways. • Partner with regional teams to ensure global strategies can be translated effectively to local healthcare systems and market requirements. • Engage external stakeholders, including payers, healthcare providers, policymakers, professional societies, and other healthcare decision-makers, to advance patient access and reimbursement objectives. Health Economics, Evidence, and Value Communication • Establish evidence-generation and health economics priorities that demonstrate the clinical, economic, patient, and healthcare system value of Neuromodulation therapies. • Partner with Clinical, Medical Affairs, R&D, and other functions to develop evidence strategies that address payer, provider, health system, and policy needs. • Oversee the development of economic analyses, real-world evidence, value propositions, reimbursement resources, and customer value tools. • Translate complex health economic, reimbursement, and market access insights into actionable business recommendations and compelling value communications. Commercialization and Customer Partnership • Partner with regional, field, and commercial teams to support product launches, therapy adoption, customer engagement, and market access execution. • Leverage patient, provider, payer, and healthcare system insights to inform portfolio strategy, evidence development, and commercialization plans. • Equip customer-facing teams with reimbursement, health economics, and value communication resources that support appropriate patient access and therapy adoption. • Support strategic engagement with healthcare systems, payers, government stakeholders, healthcare providers, and key opinion leaders. Global Functional Leadership • Lead, develop, and inspire a global HEMA organization focused on market access, reimbursement, evidence generation, health economics, and value communication. • Build organizational capabilities, operating models, and governance that support evolving Neuromodulation business needs. • Attract, develop, and retain top talent while building a strong leadership and succession pipeline. • Foster collaboration and influence across a complex, global matrixed organization. Operational Excellence, Compliance, and Quality • Establish governance, processes, and operating standards that enable effective execution of HEMA strategies. • Ensure all HEMA activities comply with applicable legal, regulatory, quality, and company requirements. • Drive continuous improvement of operating models, tools, and processes to enhance effectiveness and cross-functional collaboration. • Maintain the highest standards of scientific integrity, professionalism, patient safety, and product quality. Required Qualifications • Bachelor's degree in health economics, public health, business, life sciences, or a related field. • 15+ years of progressive experience in Health Economics, Market Access, reimbursement, health policy, or related healthcare disciplines. • 10+ years of leadership experience, including experience leading global teams and senior professionals. • Proven success developing and executing global HEMA strategies that advance patient access, evidence generation, therapy adoption, and commercial growth. • Deep knowledge of global healthcare systems, reimbursement environments, and market access requirements, including strong expertise in U.S. payer, coverage, coding, and payment systems. • Experience integrating market access and health economics strategies into product development, evidence generation, commercialization, and lifecycle management. • Significant medical device or medical technology industry experience and a strong understanding of global MedTech business operations. • Demonstrated ability to influence, lead, and drive results within complex, global matrix organizations. • Track record of building high-performing teams, developing talent, and leading organizational capability growth. • Strong executive presence and communication skills, with the ability to translate complex healthcare, reimbursement, and economic insights into business strategy and action. • Significant experience communicating with senior internal leaders and external stakeholders. • Based in Maple Grove, Minnesota (Arbor Lake) with a hybrid work schedule. • Approximately 30% travel, depending on business needs. Preferred Qualifications • Advanced degree (MBA, MPH, MHA, MS, PhD, PharmD, JD, or equivalent) in a relevant discipline. • Experience in Neuromodulation, implantable medical devices, pain management, or related therapeutic areas, with an understanding of the reimbursement, evidence, and patient-access dynamics associated with implantable therapies. • Experience developing market access and evidence strategies for physician- and/or procedure-based therapies across hospital, ambulatory, and other sites of care. • Experience working with heal